Vertex Pharmaceuticals Inc (VRTX)

Debt-to-assets ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Long-term debt	US$ in thousands	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total assets	US$ in thousands	22,730,200	21,726,200	20,349,200	18,974,200	18,150,900	16,706,400	15,582,200	14,256,100	13,432,500	12,618,700	12,221,700	12,115,100	11,751,800	11,301,600	10,216,400	8,893,200	8,318,460	7,514,550	7,033,470	6,543,110
Debt-to-assets ratio		0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

December 31, 2023 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $22,730,200K
= 0.00

The debt-to-assets ratio of Vertex Pharmaceuticals, Inc. has remained consistently low over the past eight quarters, ranging between 0.02 and 0.03. This indicates that Vertex Pharmaceuticals has a relatively low level of debt compared to its total assets. A low debt-to-assets ratio signifies a lower financial risk for the company as it suggests a good proportion of assets are funded by equity rather than debt. However, it is important to consider other factors such as the nature of the industry and overall financial health of the company when evaluating the implications of this ratio.